Lipoprotein(a) in Coronary Disease: An Emerging Novel Target (Steven E Nissen, MD) February 14, 2019
LIVESTREAM RECORDING
February 14, 2019
Lipoprotein(a) in Coronary Disease: An Emerging Novel Target”
Houston Methodist DeBakey Heart & Vascular Center, Grand Rounds Conference featuring Steven E. Nissen, MD as he discusses “Lipoprotein(a) in Coronary Disease: An Emerging Novel Target".
Introductions: William Zoghbi, MD
Speaker: Steven E. Nissen, MD, MACC
_______________________________________________________________
HOUSTON METHODIST DEBAKEY HEART & VASCULAR CENTER
GRAND ROUNDS
STATEMENT OF NEED
This program is designed, in light of reviewing quality data retrieved from weekly evaluations, to provide physicians, faculty, fellows and residents access to topics in current basic and clinical research to improve patient care.
TARGET AUDIENCE
The target audience for this activity is: Cardiology and Cardiovascular Surgery Physicians, Fellows, Residents, NPs,
PAs, Nurses, Radiologic Technologists, Sonographers and Research Coordinators.
EDUCATIONAL OBJECTIVES
At the conclusion of this activity, the participant should be able to:
• Discuss updates on diagnosis, treatment and management of cardiovascular disease.
• Integrate data and available technique in order to reach appropriate treatment decisions.
• Describe research models, methods and statistical tools.
Видео Lipoprotein(a) in Coronary Disease: An Emerging Novel Target (Steven E Nissen, MD) February 14, 2019 канала Houston Methodist DeBakey CV Education
February 14, 2019
Lipoprotein(a) in Coronary Disease: An Emerging Novel Target”
Houston Methodist DeBakey Heart & Vascular Center, Grand Rounds Conference featuring Steven E. Nissen, MD as he discusses “Lipoprotein(a) in Coronary Disease: An Emerging Novel Target".
Introductions: William Zoghbi, MD
Speaker: Steven E. Nissen, MD, MACC
_______________________________________________________________
HOUSTON METHODIST DEBAKEY HEART & VASCULAR CENTER
GRAND ROUNDS
STATEMENT OF NEED
This program is designed, in light of reviewing quality data retrieved from weekly evaluations, to provide physicians, faculty, fellows and residents access to topics in current basic and clinical research to improve patient care.
TARGET AUDIENCE
The target audience for this activity is: Cardiology and Cardiovascular Surgery Physicians, Fellows, Residents, NPs,
PAs, Nurses, Radiologic Technologists, Sonographers and Research Coordinators.
EDUCATIONAL OBJECTIVES
At the conclusion of this activity, the participant should be able to:
• Discuss updates on diagnosis, treatment and management of cardiovascular disease.
• Integrate data and available technique in order to reach appropriate treatment decisions.
• Describe research models, methods and statistical tools.
Видео Lipoprotein(a) in Coronary Disease: An Emerging Novel Target (Steven E Nissen, MD) February 14, 2019 канала Houston Methodist DeBakey CV Education
Показать
Комментарии отсутствуют
Информация о видео
14 февраля 2019 г. 20:53:32
01:19:39
Другие видео канала
2020 FH Global Summit Session 4: Lp(a) and Drivers of Inherited RiskParadigm Shifts in Myocardial Infarction Management (Navin K. Kapur, MD) October 24, 2019Physiology of Lipoproteins CholesterolLp(a) and CVD Risk: 15-Year Outcomes in the Bruneck StudyVitamin C and LipoproteinLipoprotein(a) and Atherosclerotic Cardiovascular Disease: An Age-Old Tale with a New TwistMedicine Grand Rounds: Diabetes and Cardiovascular Disease 3/26/19Cholesterol Update: LDL and Lp (a)PVCs: The Good, The Bad and The Ugly (Fermin C. Garcia, MD) February 7, 2019How Does COVID-19 Cause Cardiovascular Disease? (John P. Cooke, MD, PhD) May 11, 2020Lowering Lipoprotein(a) in CVD Patients with High Lipoprotein(a)Dr. Ron Krauss - Diet, Adiposity, and Atherogenic DyslipidemiaLp(a) 101 WebinarCardiovascular Considerations in COVID-19 Infections (Mouaz Al-Mallah, MD) April 9, 2020Update on Heart Failure with Preserved Ejection Fraction (IMAD HUSSAIN, MD) October 26, 2017Assessment of Right Ventricle (THOMAS DI SALVO, MD) May 17, 2018Managing Cholesterol: Statins and Beyond (Peter H. Jones, MD)How to Lower Lipoprotein a (LPa) Naturally?Ronald Krauss - Human Lipoprotein Responses and Cardiovascular RiskCardiac Sarcoidosis: An Elusive Disease (Arvind Bhimaraj, MD, Mouaz Al-Mallah, MD)